Deadline: 5 May 2025
The Cure Parkinson’s has launched its Quarterly Research Grant Funding Programme to primarily fund preclinical and clinical research focused on slowing, stopping, or reversing Parkinson’s.
Funding Information
- For preclinical research, they fund grants up to £250,000 (GBP) and prioritise projects that are likely to lead to clinical trials in people with Parkinson’s within 5 years.
Eligibility Criteria
- They accept applications from academics and commercial entities.
Evaluation Criteria
- If the proposed project falls within Cure Parkinson’s scope for funding, it will be considered by their independent research committee, which meets on a quarterly basis.
- At each meeting, the committee will discuss Stage 1 Applications and decide whether they should be evaluated further. If they decide that an application should be considered for funding, the applicant will be invited to submit a full application (Stage 2) and subsequently will be sent for external peer review. The feedback from the expert reviews will be discussed at the next research committee meeting, and a recommendation on whether to fund the project will be made for the Cure Parkinson’s trustees to consider. For successful applicants, the process takes approximately three months but can take longer, particularly for clinical trials where an iterative approach may apply.
- All successful and unsuccessful applicants will be notified by the chair of the research committee and/or suitable Cure Parkinson’s representative.
For more information, visit Cure Parkinson’s.
